Lumecca, with the detachable Lumecca-I spot size adaptor, delivers precise, targeted IPL procedures. Lumecca is FDA is cleared for the treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations.
Whether you're a clinic owner exploring how InMode can elevate your treatment offering, or a patient seeking more information about our technology, we'd love to hear from you. Our friendly UK team is on hand to answer your questions, recommend the right device for your clinic and arrange a personalised demonstration.